Swiss National Bank’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-161,800
| Closed | -$542K | – | 2610 |
|
|
2023
Q1 | $542K | Sell |
161,800
-19,200
| -11% | -$64.3K | ﹤0.01% | 2504 |
|
|
2022
Q4 | $871K | Buy |
181,000
+4,800
| +3% | +$23.1K | ﹤0.01% | 2411 |
|
|
2022
Q3 | $1M | Hold |
176,200
| – | – | ﹤0.01% | 2338 |
|
|
2022
Q2 | $1.25M | Buy |
176,200
+139,700
| +383% | +$992K | ﹤0.01% | 2233 |
|
|
2022
Q1 | $264K | Hold |
36,500
| – | – | ﹤0.01% | 2666 |
|
|
2021
Q4 | $326K | Hold |
36,500
| – | – | ﹤0.01% | 2712 |
|
|
2021
Q3 | $1.28M | Hold |
36,500
| – | – | ﹤0.01% | 2317 |
|
|
2021
Q2 | $784K | Buy |
+36,500
| New | +$784K | ﹤0.01% | 2551 |
|